Neeraj Kumar Pandey | Pharmaceutical Sciences | Young Scientist Award

Mr. Neeraj Kumar Pandey | Pharmaceutical Sciences | Young Scientist Award

Guru kashi university, India

Neeraj Kumar Pandey is a dedicated pharmacist from Singahi, Sahatwar, Ballia, India, with a strong passion for healthcare and pharmaceutical sciences. He holds a Diploma in Pharmacy from Guru Kashi University, where he excelled academically. With hands-on experience in hospital training and roles as a campus ambassador, NSS volunteer, and journal reviewer, he actively contributes to the healthcare sector. Neeraj has published multiple books and research articles, highlighting his expertise in pharmaceutical education. His skills include pharmaceutical dispensing, patient counseling, and content development. He has received several awards, including the International Icon Award 2024.

 

Publication Profile

Orcid

🎓 Education

Neeraj Kumar Pandey completed his high school and intermediate education under the UP Board with outstanding scores. He pursued a Diploma in Pharmacy from Guru Kashi University, achieving top marks in both years. Additionally, he completed software development training, enhancing his technical proficiency. His academic journey reflects his commitment to excellence in pharmaceutical sciences.

💼 Experience

Neeraj has gained practical experience through hospital training at SDH Talwandi Sabo and worked as Nikshay Mitra, contributing to tuberculosis eradication. He serves as a campus ambassador for PW Skills & MyGov and is an active NSS volunteer. Additionally, he reviews research articles for UGC Care List Journals, demonstrating his engagement with academic and professional communities. His diverse experience strengthens his expertise in pharmacy and healthcare.

🏆 Awards & Honors

Neeraj has been recognized with multiple prestigious awards, including the SBI Student of the Year Award 2013, Certificate of Merit, Award of Appreciation, Award of Excellence, and the International Icon Award 2024. His achievements highlight his dedication to academic excellence and contributions to healthcare and research. These accolades reflect his commitment to professional growth and leadership in the pharmaceutical sector.

🔬 Research Focus

Neeraj’s research interests span various pharmaceutical fields, including drug dispensing, patient care, and psychopharmacology. His publications cover topics such as psychosomatic disorders and erectile dysfunction in young men. He has also authored books on pharmaceutical chemistry, human anatomy, and medical ethics, emphasizing his deep engagement with research and education. His work aims to bridge knowledge gaps in pharmacy and healthcare.

Publication Top Notes

  • Mind Body Nexus: Bridging Gaps in Psychosomatic Disorders Treatment and Assessment for Holistic Care
    Goya Journal, 2024-02-24 | Journal article
    Contributors: Neeraj Kumar Pandey, Devinder Maheswary

 

  • Cognite: Pharmaceutical Chemistry
    Notion Press Media Pvt. Ltd., 2024-02-02 | Book
    Contributors: Neeraj Kumar Pandey, Inderjeet Kaur

 

  • Atharva: A Medicinal Plants Handbook
    Notion Press Media Pvt. Ltd., 2024-01-19 | Book
    Contributors: Neeraj Kumar Pandey, S. Pargat Singh

 

  • Pharmaceutical Practical Handbook
    Notion Press Media Pvt. Ltd., 2024-01-10 | Book
    Contributors: Neeraj Kumar Pandey, Dr. Devinder Kumar Maheshwari

 

Ildoo Chung | Pharmacology | Best Researcher Award

Prof. Dr. Ildoo Chung | Pharmacology | Best Researcher Award

 Professor, Pusan National University South Korea

Ildoo Chung is a distinguished professor in the Department of Polymer Science and Engineering at Pusan National University, Korea. With a career spanning over two decades, he specializes in polymer chemistry, functional materials, and advanced biomedical engineering applications. Dr. Chung has held prominent academic and administrative positions, including department head and associate dean. He actively contributes to global research through editorial roles, conference leadership, and professional society memberships. Renowned for his dedication to education and innovation, Dr. Chung’s work bridges academia and industry, advancing polymer science worldwide.

Publication Profile

Scopus

Orcid

google scholar

🎓 Education

Ph.D. in Polymer Science & Engineering, Pusan National University, Korea (2000.08). M.S. in Polymer Science & Engineering, Pusan National University, Korea (1997.02). B.S. in Polymer Science & Engineering, Pusan National University, Korea (1995.02)

💼 Experience

Professor, Pusan National University, Korea (2014–present). Associate Dean, College of Engineering, Pusan National University (2018–2020). Department Head, Polymer Science & Engineering, Pusan National University (2013–2017). Visiting Associate Professor, University of Tennessee, USA (2012–2013). Assistant/Associate Professor, Pusan National University (2005–2014). Postdoctoral Fellow, University of Alabama at Birmingham, USA (2000–2002)

🏆 Awards & Honors

Member, Board of Directors, The Polymer Society of Korea. Editorial roles in Journal of Adhesion and Interface, IJMSE, and others. Numerous conference chair and committee memberships globally. Reviewer for high-impact journals like Macromolecular Research and Dental Materials. Recipient of national and international recognition for polymer research

🔬 Research Focus

Development of functional polymers for drug delivery and biomedical applications. Advanced polymer composites and their industrial applications. Interface engineering in polymer systems for sustainability. Nanostructured materials and their multifunctional properties. Polymer chemistry for healthcare innovations

Conclusion

Professor Ildoo Chung’s academic and professional journey reflects a commitment to advancing knowledge in polymer science and materials engineering. His leadership, research, and editorial work have significantly impacted the field, making him a deserving candidate for the Best Researcher Award. With continued efforts in interdisciplinary collaboration and practical applications, he has the potential to further elevate his influence and contributions to global scientific advancements.

Publication Top Notes

  • Title: L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
    Year: 2024
    Authors: Seoeun Oh, Soo-Yong Park, Hyung Il Seo, Ildoo Chung
    Citation: DOI: 10.3390/pharmaceutics17010028

 

  • Title: Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44
    Year: 2024
    Authors: Vo Van Giau, Giau Van Vo, Van-Giau Vo, Ildoo Chung, Chang-Sik Ha, Seong An, Yang H. Yun
    Citation: DOI: 10.3390/pharmaceutics16060836

 

  • Title: Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine
    Year: 2023
    Authors: Sivagangi Reddy Nagella, Soojeong Choi, Soo-Yong Park, Chang-Sik Ha, Youngmi Jung, Ramesh Kumar Chitumalla, Joonkyung, Ji-Young Yoon, Ildoo Chung
    Citation: DOI: 10.3390/ijms242216470

 

  • Title: Effects of Recycled Polymer on Melt Viscosity and Crystallization Temperature of Polyester Elastomer Blends
    Year: 2023
    Authors: Ji-Eun Lee, Jin-Woo Lee, Jae-Wang Ko, Kyung-Il Jo, Hyun-Ju Park, Ildoo Chung
    Citation: DOI: 10.3390/ma16176067

 

  • Title: Carboxymethyl cellulose/montmorillonite bionanocomposite films incorporated with polyhedral oligomeric silsesquioxane
    Year: 2022
    Authors: Jin H., Yan Y.-Z., Lee C.S., Lee J.-H., Chung I., Ha C.-S.
    Citation: DOI: 10.1080/09276440.2022.2151262

 

  • Title: Effect of the Surface Modification of Silica Nanoparticles on the Viscosity and Mechanical Properties of Silica/Epoxy Nanocomposites
    Year: 2022
    Authors: Kim T., Kwon S.-H., Kim H.J., Lim C.-S., Chung I., Lee W.-K., Seo B.
    Citation: DOI: 10.1080/09276440.2022.2094572

 

  • Title: Polydopamine/Polypyrrole Modified Graphite Felt Enhances Biocompatibility for Electroactive Bacteria and Power Density of Microbial Fuel Cell
    Year: 2022
    Authors: Kim M., Li S., Kong D.S., Song Y.E., Park S.-Y., Kim H.-I., Jae J., Chung I., Kim J.R.
    Citation: EID: 2-s2.0-85133636105

 

  • Title: Polyol and Polyurethane Containing Bisphenol-Z: Synthesis and Application for Toughening Epoxy
    Year: 2022
    Authors: Lee D.Y., Kim H.J., Kim H.-G., Lim C.-S., Chung I., Seo B.
    Citation: DOI: 10.1002/app.53013

 

  • Title: ROS- and pH-Responsive Polydopamine Functionalized Ti₃C₂Tₓ MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Veena Vijayan, Lee Jun Seok, Sung Soo Park, Xiuguo Cui, Ildoo Chung, Jaejun Lee, Suk-kyun Ahn, Jung Rae Kim, et al.
    Citation: DOI: 10.3390/nano12244392

 

  • Title: Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-kyun Ahn, Jung Rae Kim, Chang-Sik Ha
    Citation: DOI: 10.3390/ijms232314925

 

 

Daniela Malengo | Pharmacology | Women Researcher Award

Dr. Daniela Malengo | Pharmacology | Women Researcher Award

Dr at Istituto Europeo di Oncologia, Italy

Daniela Malengo, an Italian pharmacist, is currently the Vice Director of the Hospital Pharmacy Division at Istituto Europeo di Oncologia, Milan. With a career spanning over 15 years, Daniela specializes in oncology drug management, hospital pharmacy administration, and medical device protocols. She is passionate about optimizing pharmaceutical practices and contributing to oncology care. Throughout her career, she has been dedicated to ensuring the safe and effective use of drugs in oncological treatments and has supported numerous research projects. Her leadership skills also extend to teaching pharmacy students through internships and projects.

Profile

Scopus

🎓 Education 

Management of CAR-T Patients, LIUC Business School (Dec 2023–Mar 2024). Hospital Pharmacy Management, Università Bocconi, Milan (Sept 2019–Dec 2020). Specialization in Applied Pharmacology, University of Pavia (2005–2009). Degree in Pharmacy, University of Pavia (2000–2005). State Exam for Pharmacist License, University of Pavia (Nov–Dec 2005). Scientific High School Diploma, Liceo Scientifico N. Copernico, Pavia (1995–2000)

💼 Experience

Vice Director of Hospital Pharmacy Division, Istituto Europeo di Oncologia, Milan (July 2023–Present): Managing narcotic drug dispensation and overseeing oncological therapy. Assistant Pharmacist, Istituto Europeo di Oncologia, Milan (Mar 2011–July 2023): Managed medical devices and chemotherapy prescriptions. Pharmacist – Research Fellow, Istituto Europeo di Oncologia, Milan (May 2006–Feb 2011): Supervised experimental drugs and contributed to research on oncological drug appropriateness. Intern (2004–2005): Worked at Farmacia Dott. A. Lodola, Siziano, dispensing medications to the public.

🏆 Awards & Honors

Numerous presentations at national congresses, including SIFO Congress (2009–2010). Recognized for contributions to hospital pharmacy management and cost analysis of oncological treatments. Leadership roles in pharmacy student internships and research programs. Awarded for excellence in promoting safe oncological drug usage.

🔬 Research Focus

Oncology Pharmacology: Focuses on managing oncological drug appropriateness, chemotherapy prescriptions, and medical device protocols. Pharmacy Management: Expertise in hospital pharmacy operations, including drug dispensation, quality control, and patient safety. Experimental Pharmacology: Managed experimental drugs and contributed to clinical research in oncological treatments. Cost Analysis: Focus on managing hospital pharmacy expenses and evaluating drug cost-effectiveness.

Conclusion

Daniela Malengo’s career exemplifies dedication to hospital pharmacy, oncological drug management, and the advancement of healthcare systems through her research and leadership roles. Her consistent contributions to improving patient outcomes in oncology, coupled with her academic excellence, make her a strong candidate for the Women Researcher Award. With her continued focus on improving the quality of healthcare services and mentoring future professionals, Daniela’s future contributions are poised to have a lasting impact in both the pharmacy and healthcare sectors.

📚Publications 

  • The Prolonged Clinical Benefit with Metronomic Chemotherapy (VEX Regimen) in Metastatic Breast Cancer Patients
    • Authors: Montagna, E., Pagan, E., Cancello, G., Viale, G., Colleoni, M.
    • Journal: Anti-Cancer Drugs
    • Volume: 33
    • Issue: 1
    • Pages: E628–E634
    • Year: 2022
    • Citations: 6

 

  • Management of Breast Cancer Patients During the Peak of the COVID-19 Pandemic
    • Authors: Montagna, E., Bellerba, F., Sangalli, C., Colleoni, M., Veronesi, P.
    • Journal: European Journal of Surgical Oncology
    • Volume: 47
    • Issue: 10
    • Pages: 2694–2695
    • Year: 2021
    • Citations: 2

 

Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr. Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr at St. Jude Children’s Research Hospital, United States

Srijan Acharya is a dedicated scientist with expertise in molecular pharmacology and cancer genomics. He is currently a Post-Doctoral Research Fellow at St. Jude Children’s Research Hospital, focusing on childhood cancer research. With 32 published scientific articles and a total citation count of over 385, his work has contributed significantly to biomarker discovery, receptor pharmacology, and immuno-oncology. His research aims to address therapeutic resistance in pediatric malignancies through small molecule screening. Srijan is fluent in English, Bangla, and Hindi, with basic knowledge of Korean.

Profile

Scholar

🎓 Education

PhD in Molecular Pharmacology from Chonnam National University, South Korea (2020). M.Sc. in Biotechnology from North South University, Bangladesh (2015). BPHRM in Pharmacy from East West University, Bangladesh (2012). His academic journey has provided a strong foundation in receptor pharmacology and molecular biology, guiding his transition into cancer research.

💼 Experience

Post-Doctoral Research Fellow, Pharmacy Department, St. Jude Children’s Research Hospital, USA (2023-Present). Post-Doctoral Research Fellow, Pathology Department, Mitchell Cancer Institute, USA (2020-2023). Executive Officer, Research and Development, Square Pharmaceutical PLC, Bangladesh (2012-2013). His experience spans academia and industry, with a focus on cancer research, receptor signaling, and small molecule screening.

🏆 Awards and Honors

Inducted into Sigma Xi, The Scientific Research Honor Society (2023). Recognized in Who’s Who in America by Marquis (2023). Young Investigator Award at AACR conference by AAISCR (2022). Best Presenter Award from China Pharmaceutical University (2021). Global Scholarship from Chonnam National University, Korea (2015). These accolades reflect his significant contributions to molecular pharmacology and cancer research.

🔬 Research Focus

Srijan’s research primarily investigates the role of molecular signaling in cancer, focusing on the interaction of nicotine receptors with GPCRs and their impact on cancer progression. At St. Jude, his work focuses on childhood cancers, particularly Ewing sarcoma and rhabdomyosarcoma. He uses small molecule screening to discover potential therapeutic agents and aims to overcome therapeutic resistance in pediatric cancers.

Conclusion

Srijan Acharya is a highly accomplished and promising researcher whose contributions to cancer pharmacology and molecular biology are noteworthy. His interdisciplinary research approach, combined with his dedication to advancing pediatric oncology, positions him as a leader in the field. With continued mentorship and broader collaborative efforts, Acharya is well poised for even greater achievements, further solidifying his place as an influential scientist in the biomedical community.

📚Publications 

  • Title: Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβII
    Year: 2024
    Authors: Dooti K, Acharya S, Wang S, Kim K.M.

 

  • Title: Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
    Year: 2023
    Authors: Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP

 

  • Title: MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
    Year: 2023
    Authors: Md Khan, S Acharya, S Anand, F Sameeta, P Pramanik, C Keel, S Singh, James E Carter, S Dasgupta, A Singh

 

  • Title: Comparative study of the molecular mechanisms underlying the G protein and β-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor
    Year: 2023
    Authors: Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, Li H, Zhang X

 

  • Title: Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis
    Year: 2023
    Authors: Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S.

 

  • Title: Nicotine causes alternative polarization of macrophages via Src-mediated STAT3 activation: Potential pathobiological implications
    Year: 2022
    Authors: Acharya S, Saranyutanon S, Deshmukh SK, Khan MA, Singh S, Singh AP

 

  • Title: β-Arrestin1 and GRK2 play permissive roles in Src-mediated endocytosis of α4β2 nicotinic acetylcholine receptor
    Year: 2021
    Authors: Acharya S, Kundu D, Kim KM

 

  • Title: Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
    Year: 2021
    Authors: Acharya S, Kim KM

 

  • Title: Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer
    Year: 2021
    Authors: Miree, O., Srivastava, …Acharya S.et al.

 

  • Title: Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation
    Year: 2020
    Authors: Acharya S, D. Kundu, H.J. Choi, and K.M. Kim

 

  • Title: Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
    Year: 2019
    Authors: Acharya S, Kim M., Botanas C. J., Custodio R. J., Lee H. J., Sayson L. V., Kim H. J.

 

  • Title: Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors
    Year: 2017
    Authors: Paudel S, Acharya S, Yoon G, Kim K.M., & Cheon S.H.

 

Afif Ben Mahmoud | Genomics | Excellence in Research

 Dr. Afif Ben Mahmoud | Genomics | Excellence in Research  

 Dr at Qatar Biomedical Research Institute,  Qatar

Afif Ben Mahmoud, Ph.D., is a Senior Research Associate at the Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, in Doha, Qatar. A Tunisian national, Dr. Ben Mahmoud specializes in human molecular genetics and has dedicated over ten years to researching neurological disorders and genetic diseases. He holds a Ph.D. in Biological Sciences and has made significant contributions to understanding neurodevelopmental disorders through innovative research techniques and mentoring graduate students. His work emphasizes the identification of genetic factors in various disorders, making him a vital asset to the scientific community in Qatar and beyond.

Profile

Scopus

Scholar

Education 🎓

Dr. Ben Mahmoud earned his Ph.D. in Biological Sciences (Human Molecular Genetics) from the Faculty of Sciences of Sfax, University of Sfax, Tunisia, in 2015. Prior to this, he obtained a Master’s degree in Genetics and Biodiversity from the Higher Institute of Biotechnology of Monastir, Tunisia, in 2009. His academic journey began with an Engineering degree in Animal Production from the Higher School of Agronomy of Mateur, University of Carthage, Tunisia, in 2007. This solid educational foundation has equipped him with the necessary skills and knowledge to excel in his research endeavors.

Experience 💼

Since 2019, Dr. Ben Mahmoud has served as a Senior Research Associate at the Qatar Biomedical Research Institute, where he identifies and characterizes candidate genes for neurodevelopmental disorders by analyzing whole exome and whole genome sequencing data. Before this, he was a Postdoctoral Researcher at the College of Medicine and Health Sciences, University of UAE, from 2016 to 2018, focusing on genomic and cellular studies of autosomal recessive disorders. He has also taught cell biology and genetics at various higher education institutions in Tunisia, contributing to the academic development of future scientists.

Awards and Honors 🏆

Dr. Ben Mahmoud has received recognition for his contributions to genetic research and education. He participated in the development of cell lines using CRISPR-Cas9 technology at UAEU, which aims to better understand diseases. His work has been featured in multiple peer-reviewed publications, establishing him as an authority in his field. He has been actively involved in mentoring students, fostering the next generation of researchers, and enhancing the academic environment in which he works.

Research Focus 🔬

Dr. Ben Mahmoud’s research primarily focuses on neurological disorders and human genetic diseases, specifically identifying the genetic basis of neurodevelopmental disorders. He employs advanced techniques such as next-generation sequencing and molecular biology methods to analyze candidate genes. His recent studies aim to elucidate the cellular mechanisms behind disease-causing mutations, contributing to the broader understanding of genetic disorders. Dr. Ben Mahmoud’s work is instrumental in developing targeted therapeutic strategies, enhancing the potential for personalized medicine in treating complex genetic conditions.

Conclusion 📝

Dr. Afif Ben Mahmoud exemplifies excellence in research through his substantial contributions to the field of neurological disorders and human genetics. His extensive experience, technical expertise, and commitment to mentorship position him as a strong candidate for the Excellence in Research Award. By addressing potential areas for improvement, such as broadening his research focus and enhancing public engagement, Dr. Ben Mahmoud could further amplify his impact within the scientific community and beyond. His ongoing work promises to advance our understanding of complex genetic diseases, making him a valuable asset to the field.

Publications Top Notes

  • Antagonist effects of Bacillus spp. strains against Fusarium graminearum for protection of durum wheat (Triticum turgidum L. subsp. durum)
    • Authors: I Zalila-Kolsi, AB Mahmoud, H Ali, S Sellami, Z Nasfi, S Tounsi, …
    • Journal: Microbiological Research, 2016
    • Pages: 148-158

 

  • Mitochondrial DNA mutations and polymorphisms in asthenospermic infertile men
    • Authors: S Baklouti-Gargouri, M Ghorbel, A Ben Mahmoud, E Mkaouar-Rebai, …
    • Journal: Molecular Biology Reports, 2013
    • Volume/Pages: 40, 4705-4712

 

  • A novel mutation MT-COIII m.9267G>C and MT-COI m.5913G>A mutation in mitochondrial genes in a Tunisian family with maternally inherited diabetes and deafness (MIDD)
    • Authors: M Tabebi, E Mkaouar-Rebai, M Mnif, F Kallabi, AB Mahmoud, WB Saad, …
    • Journal: Biochemical and Biophysical Research Communications, 2015
    • Volume/Pages: 459(3), 353-360

 

  • Genetics of hypogonadotropic hypogonadism—Human and mouse genes, inheritance, oligogenicity, and genetic counseling
    • Authors: ED Louden, A Poch, HG Kim, A Ben-Mahmoud, SH Kim, LC Layman
    • Journal: Molecular and Cellular Endocrinology, 2021
    • Volume: 534, 111334

 

  • Identification of a novel m.9588G>A missense mutation in the mitochondrial COIII gene in asthenozoospermic Tunisian infertile men
    • Authors: S Baklouti-Gargouri, M Ghorbel, A Ben Mahmoud, E Mkaouar-Rebai, …
    • Journal: Journal of Assisted Reproduction and Genetics, 2014
    • Volume/Pages: 31, 595-600

 

  • A novel aberrant splice site mutation in COL27A1 is responsible for Steel syndrome and extension of the phenotype to include hearing loss
    • Authors: N Gariballa, A Ben-Mahoud, M Komara, AM Al-Shamsi, …
    • Journal: American Journal of Medical Genetics Part A, 2017
    • Volume/Pages: 173(5), 1257-1263

 

  • Whole mitochondrial genome screening of a family with maternally inherited diabetes and deafness (MIDD) associated with retinopathy: A putative haplotype associated to MIDD and its phenotypic implications
    • Authors: M Tabebi, N Charfi, F Kallabi, O Alila-Fersi, AB Mahmoud, A Tlili, …
    • Journal: Journal of Diabetes and its Complications, 2017
    • Volume/Pages: 31(1), 253-259

 

  • Two novel mutations in COII and tRNAHis mitochondrial genes in asthenozoospermic infertiles men
    • Authors: BG Siwar, G Myriam, BM Afif, MR Emna, C Nozha, S Afifa, F Faiza, …
    • Journal: Biochemical and Biophysical Research Communications, 2014
    • Volume/Pages: 450(1), 610-615

 

  • A novel m.6307A>G mutation in the mitochondrial COXI gene in asthenozoospermic infertile men
    • Authors: S Baklouti-Gargouri, M Ghorbel, A Ben Mahmoud, E Mkaouar-Rebai, …
    • Journal: Molecular Reproduction and Development, 2013
    • Volume/Pages: 80(7), 581-587

 

  • Bacillus amyloliquefaciens: Harnessing Its Potential for Industrial, Medical, and Agricultural Applications—A Comprehensive Review
    • Authors: I Zalila-Kolsi, A Ben-Mahmoud, R Al-Barazie
    • Journal: Microorganisms, 2023
    • Volume/Pages: 11(9), 2215

 

  • Novel cases of Tunisian patients with mutations in the gene encoding 17β-hydroxysteroid dehydrogenase type 3 and a founder effect
    • Authors: BB Rhouma, F Kallabi, N Mahfoudh, AB Mahmoud, RT Engeli, H Kamoun, …
    • Journal: The Journal of Steroid Biochemistry and Molecular Biology, 2017
    • Volume/Pages: 165, 86-94

 

  • Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish
    • Authors: YR Lee, SH Kim, A Ben-Mahmoud, OH Kim, TI Choi, KH Lee, B Ku, J Eum, …
    • Journal: Human Molecular Genetics, 2021
    • Volume/Pages: 30(5), 331-342

 

N T Pramathesh Mishra | Pharmacology | Young Scientist Award

Assoc Prof Dr. N T Pramathesh Mishra | Pharmacology| Young Scientist Award

Associate Professor at Department of Pharmacology, Goel Institute of Pharmacy and Sciences, Lucknow, Uttar Pradesh, India, 226028

As an accomplished Associate Professor in Pharmacology, I aim to contribute to innovative scientific research, advanced drug discovery, and training future healthcare professionals . With over a decade of experience and recognition, including awards like the Daniel Bovet Distinguished Young Scientist Award and Karma Veer Chakra Global Youth Fellowship , I am dedicated to advancing pharmacology and fostering collaborative research initiatives . My goal is to engage in cutting-edge research, impactful workshops, and inspire the next generation of scientists and healthcare providers

Publication

    1. Effect of COVID-19 Pandemic Lockdowns on Planned Cancer Surgery for 15 Tumour Types in 61 Countries
      Journal: The Lancet Oncology
      Year: 2021
      Citations: 256

     

    1. Global Impacts of Pre-and Post-COVID-19 Pandemic: Focus on Socio-Economic Consequences
      Journal: Sensors International
      Year: 2020
      Citations: 140

     

    1. Endophyte-Mediated Modulation of Defense-Related Genes and Systemic Resistance in Withania somnifera (L.) Dunal Under Alternaria alternata Stress
      Journal: Applied and Environmental Microbiology
      Year: 2018
      Citations: 77

     

    1. Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease
      Journal: Frontiers in Pharmacology
      Year: 2022
      Citations: 30

     

    1. Supplementation of Trichoderma Improves the Alteration of Nutrient Allocation and Transporter Genes Expression in Rice Under Nutrient Deficiencies
      Journal: Plant Physiology and Biochemistry
      Year: 2019
      Citations: 23

     

    1. Clinicomycological Study of Dermatophytoses in Children Presenting at a Tertiary Care Center
      Journal: Indian Journal of Paediatric Dermatology
      Year: 2018
      Citations: 21

    Conclusion

    N T Pramathesh Mishra is a strong candidate for the Young Scientist Award due to his robust academic background, impactful research contributions, and recognition through prestigious awards. His diverse experience, innovative patents, and involvement in significant research projects reflect his potential as a leading young scientist. Addressing the areas for improvement, particularly in publication and broader collaboration, could further strengthen his candidacy and enhance his impact in the scientific community.

Daniele Florio | Pharmaceutical science | Young Scientist Award

Mr. Daniele Florio | Pharmaceutical science | Young Scientist Award

Daniele Florio is a dedicated researcher in pharmaceutical sciences, currently pursuing a Ph.D. at the University of Naples Federico II. His doctoral work focuses on integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia, scheduled for completion in October 2024. Daniele brings extensive experience from his Marie Sklodowska-Curie secondment and voluntary internship, specializing in peptide synthesis, mass spectrometry, and spectroscopic techniques. With a strong publication record and active participation in international conferences, he contributes significantly to the fields of amyloid aggregation, chemical catalysis, and drug development, showcasing advanced skills in scientific research and analysis.

Profile

Scopus

👨‍🏫Professional Experience

Tutoring Activities (Grant Type B) 2023-2024, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Provided supplementary teaching for Chemistry and Inorganic Chemistry courses for Pharmacy and CTF degree students. Ph.D. Candidate in Pharmaceutical Sciences (XXXVII Cycle) 2021 – Present, Naples, Italy, Department of Pharmacy, University of Naples Federico II, PhD Project: Integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia., Scheduled PhD end: October 31, 2024. Secondee under Marie Skłodowska-Curie Research and Innovation Staff Exchange Action June 2022 – March 2023, Dublin, Ireland, Keladapharmachem, Participated in the GreenX4Drug (EU funded H2020 RISE project), focusing on developing novel asymmetric chemical catalysts for manufacturing high-value APIs and advanced intermediates.. Voluntary Internship Post-Degree 2018 – 2019, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Designed, synthesized, and characterized peptides, peptidomimetics, and small molecules using solid-phase and solution methodologies. Utilized mass spectrometry (ESI) for identifying synthetic compounds and applied analytical and preparative methodologies (HPLC) for their purification and characterization. Conducted structural and functional characterization of biomolecules through spectroscopic techniques (CD, Fluorescence, SPR, UV-Vis). Supervisor: Prof. Daniela Marasco

🎓Education and Training

Biologist Board Examination February 7, 2022, University of Naples Federico II, Naples, Italy Master’s Degree in Biological Science (Molecular Diagnostics Field) July 12, 2021, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Protein fragments of Nucleophosmin 1 as models of amyloids”, Supervisor: Prof. Antonello Merlino, Co-Supervisor: Prof. Daniela Marasco,k Grade: 110/110. Bachelor’s Degree in Biological Science (Molecular Diagnostics Field) March 15, 2018, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Amyloid-like aggregation of Nucleophosmin 1 regions related to Acute Myeloid Leukemia: spectroscopic studies” Supervisor: Prof. Daniela Marasco Grade: 106/110

📖Certifications

English TELSA C1, Grade B Language Certification ESAT, Malta Further & Higher Education Authority

Skills and Competencies

Organizational Skills

  • Efficient under pressure.
  • Adaptive to changes and new situations.
  • Strong independent work organization and goal achievement.

Job-related Skills

  • Solid-phase peptide synthesis and combinatorial peptide libraries using Fmoc/Boc chemistry.
  • Experience with various peptide synthesizers (BIOTAGE, Liberty Blue 2.0).
  • Proficient in analysis and purification using ESI mass spectrometry, HPLC, and flash purification systems.
  • Skilled in spectroscopic techniques (CD, Fluorescence, DLS, SPR, UV-Vis, FTIR, NMR).

Digital Skills

  • Proficient in Microsoft Office Suite.
  • Experienced with operating systems: MS-Windows, MacOS, LINUX.
  • Proficient in scientific data analysis software (GraphPad Prism).
  • Knowledgeable in databases (PubMed) and bibliographic management software (EndNote, Mendeley).
  • Proficient with video conferencing software (Teams, Skype, Zoom, Google Meet).
  • Excellent knowledge of major browsers (Edge, Chrome, Firefox, Safari, Opera).

🌍Projects

National Project Participation

  • BANDO-PRIN-2022. Research Project: Design, synthesis, and investigation of novel G-quadruplex aptamers against STAT3 and the interleukin-6 receptor (G4-APTASTAT).
  • Project Coordinator and Head of Research Unit: Prof. GALEONE Aldo

Bibliometric Parameters

  • H-index from Scopus: 11
  • Number of Publications: 24
  • Citations: 388

 

Publications Top Notes 📝

  • The effects of histidine substitution of aromatic residues on the amyloidogenic properties of the fragment 264–277 of nucleophosmin 1
    • Authors: D. Florio, P. Luciano, C. Di Natale, D. Marasco
    • Journal: Bioorganic Chemistry
    • Volume: 147
    • Year: 2024
    • Pages: 107404

 

  • Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
    • Authors: D. Florio, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 25
    • Issue: 2
    • Year: 2024
    • Pages: 811

 

  • Modulation of hydrogel networks by metal ions
    • Authors: S. La Manna, D. Florio, C. Di Natale, D. Marasco
    • Journal: Journal of Peptide Science
    • Volume: 29
    • Issue: 8
    • Year: 2023
    • Article ID: e3474

 

  • Ruthenium complexes bearing glucosyl ligands are able to inhibit the amyloid aggregation of short histidine-peptides
    • Authors: D. Florio, S. La Manna, A. Annunziata, M. Monti, D. Marasco
    • Journal: Dalton Transactions
    • Volume: 52
    • Issue: 25
    • Year: 2023
    • Pages: 8549–8557

 

  • Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1
    • Authors: D. Florio, S. La Manna, C. Di Natale, A.M. Malfitano, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 23
    • Issue: 23
    • Year: 2022
    • Pages: 14704

 

  • Hydrogelation tunability of bioinspired short peptides
    • Authors: S. La Manna, D. Florio, V. Panzetta, C. Di Natale, D. Marasco
    • Journal: Soft Matter
    • Volume: 8
    • Year: 2022
    • Pages: 8

 

Faiyaz Shakeel |Pharmaceutical sciences | Best Researcher Award

 Prof Dr. Faiyaz Shakeel | Pharmaceutical sciences |Best Researcher Award

Prof Dr. King Saud University, Saudi Arabia

👩‍🔬Highly accomplished in pharmaceutics, holds a Ph.D. and M. Pharm. from Jamia Hamdard University, India. With extensive experience as a Professor and Associate Professor at King Saud University, Riyadh, Saudi Arabia, and previous roles in academia and research, he excels in formulation research and development. His expertise spans nanoemulsions and transdermal dosage forms, contributing significantly to the field. Driven by a passion for innovation, he led groundbreaking projects, optimizing drug delivery systems for enhanced therapeutic outcomes. Eager to leverage his skills and knowledge, he seeks to join a renowned research organization, fostering growth and advancement in pharmaceutical sciences.🌟

 

Profile

 

Scholar

 

🎓  Objectives

Seeking association with a renowned research organization in formulation research and development to upgrade knowledge, research, and management skills in line with the latest trends. Eager to be part of a dynamic team contributing to organizational growth.

📚  Qualification Overview

Doctor of Philosophy (Ph.D.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2004-2007. Master of Pharmacy (M. Pharm.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2002-2004. Bachelor of Pharmacy (B. Pharm.), Jamia Hamdard University, New Delhi, India, 1998-2002.

👨‍🏫 Professional Experience

Professor, King Saud University, Riyadh, Saudi Arabia (Feb 2022 – Present) Associate Professor, King Saud University, Riyadh, Saudi Arabia (Mar 2016 – Feb 2022) Assistant Professor, King Saud University, Riyadh, Saudi Arabia (Nov 2011 – Mar 2016) Lecturer, Garyounis University, Benghazi, Libya (Nov 2007 – Nov 2011) Senior Lecturer, Bhawani Shankar Anangpuria Institute of Pharmacy, Faridabad, India (Aug 2006 – Oct 2007) Guest Lecturer, Shri Gopichand College of Pharmacy, Baghpat, India (Jul 2004 – Jun 2006)

🏅  Professional Qualification

Ph.D. Title: Formulation and development of transdermal dosage form (Nanoemulsions) for antirheumatoid drug, Jamia Hamdard University, New Delhi, India, 2004-2007. M. Pharm. Title: Development and evaluation of bioadhesive transdermal gels of diclofenac diethylamine, Jamia Hamdard University, New Delhi, India, 2002-2004. B. Pharm., Jamia Hamdard University, New Delhi, India, 1998-2002.

🔬 Practical Experience

Master’s Research Project: Developed bioadhesive transdermal gels for diclofenac diethylamine. Ph.D. Thesis: Developed nanoemulsion and nanoemulsion gel formulations of celecoxib and aceclofenac for arthritis.

🔍Conclusion of Research Projects

Master’s Project: Optimized gel showed controlled drug release and significant anti-inflammatory effects. Ph.D. Thesis: Developed nanoemulsion formulations with controlled release, higher absorption, and significant pharmacodynamic effects.

Publications Top Notes 📝

  • Development and bioavailability assessment of ramipril nanoemulsion formulation
    • Authors: S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
    • Journal: European journal of pharmaceutics and biopharmaceutics
    • Year: 2007
    • Volume: 66
    • Issue: 2
    • Pages: 227-243
    • Citations: 1006

 

  • Nanoemulsions as vehicles for transdermal delivery of aceclofenac
    • Authors: F Shakeel, S Baboota, A Ahuja, J Ali, M Aqil, S Shafiq
    • Journal: Aaps Pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: 191-199
    • Citations: 427

 

  • Formulation development and optimization using nanoemulsion technique: a technical note
    • Authors: S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, …
    • Journal: AAPS pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: E12-E17
    • Citations: 420

 

  • Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
    • Authors: S Baboota, F Shakeel, A Ahuja, J Ali, S Shafiq
    • Journal: Acta pharmaceutica
    • Year: 2007
    • Volume: 57
    • Issue: 3
    • Pages: 315-332
    • Citations: 397

 

  • A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
    • Authors: A Muheem, F Shakeel, MA Jahangir, M Anwar, N Mallick, GK Jain, …
    • Journal: Saudi Pharmaceutical Journal
    • Year: 2016
    • Volume: 24
    • Issue: 4
    • Pages: 413-428
    • Citations: 384

 

Annesha Chakraborty| Bioinformatics | Women Researcher Award

 Dr. Annesha Chakraborty | Bioinformatics | Women Researcher Award

 Dr. SASTRA DEEMED UNIVERSITY

👩‍🔬 A highly motivated Ph.D. candidate at SASTRA Deemed University, specializing in Bioinformatics and Biomolecular Crystallography, with hands-on experience in molecular docking, dynamics, and laboratory techniques. Possessing an M.Sc. in Microbiology and B.Sc. (Hons.) in Microbiology, Chemistry, and Botany, I excel in research and academic achievements. As a Research Intern at MEAB LAB and Lab Tech. Intern at Suraksha Diagnostic Pvt. Ltd., I contributed to multiple publications and gained expertise in DNA/RNA extraction and PCR. Currently engaged in molecular dynamics studies on COVID Mpro, biomass production, and A.baumannii’s efflux pump research. Passionate about advancing scientific knowledge and addressing real-world challenges.🌟

 

Profile

Orcid

Scholar

 

🎓 Education

Doctor of Philosophy (2023-Ongoing) SASTRA Deemed University, India Bioinformatics Center and Biomolecular Crystallography Lab, under the supervision of Dr. S. Thamotharan and co-supervision of Dr. Vigneshwer R. Currently pursuing research funded by DBT-govt. of India. M.Sc in Microbiology (2020-2022) Grade: A+ (80%) [Ranked 4th] B.Sc (Hons.) in Microbiology (2017-2020) Optional subjects: Chemistry and Botany Grade: B+ 12th (High School) (2015-2017) Science stream

🔬 Key Skills

  • Molecular Docking
  • Molecular Dynamics
  • Schrodinger
  • Pymol
  • MegaAUTODOCK
  • Agarose Gel Electrophoresis
  • ELISA
  • qPCR
  • RT-PCR
  • Flow Cytometry
  • Online tools for nucleic acid or protein sequence-based analysis (Expasy, Clustal Omega, NCBI)

💼 Work Experience

Research Intern at MEAB LAB (08/2021-09/2022) JIS University (Hybrid mode) Responsibilities: Worked on current research projects with PhD scholars as a Project Associate Intern. Co-authored 3 review articles and 1 book chapter, and contributed to 3 research projects. Previously worked here for Master’s thesis paper. Lab Tech Intern at Suraksha Diagnostic Pvt. Ltd. (12.08.2022-24.08.2022) Responsibilities: Conducted DNA and RNA extraction for PCR to detect HLA, hepatitis B, hepatitis C, and Covid-19 virus. Performed RT-PCR and real-time PCR to detect RNA and DNA viruses.

Publications Top Notes 📝

  1. Title: Lignocellulolytic Microbial Systems and its Importance in Dye Decolourization: A Review

 

  1. Title: Microbial electrolysis cells for effective biohydrogen biogenesis from biowastes

 

  1. Title: Algae educed industrial enzymes production: a sustainable way forward?
    • Book: Industrial Microbiology
    • ISBN: 978-93-5461-997-7
    • Publisher: Astral International Pvt. Ltd. (Scopus)

Somayeh Hashemi Sheikhshabani | Human Genetics | Best Researcher Award

Dr. Somayeh Hashemi Sheikhshabani | Human Genetics | Best Researcher Award

👨‍🏫Profile Summary

I am a highly skilled researcher specializing in Medical Genetics with a focus on Cancer Biology, Cancer Drug Resistance, Noncoding RNAs, Computational Biology, and Genetics of Rare Diseases. With a Ph.D. from Shahid Beheshti University of Medical Sciences, Tehran, Iran, and a strong background in Cellular and Molecular Biology, I’ve conducted extensive research on genetic analysis of male infertility, identification of genes involved in various cancers, and prediction of regulatory networks using bioinformatics tools. Proficient in a wide range of experimental techniques and software applications, I am dedicated to advancing knowledge in genetics and contributing to the development of innovative therapies.

 

🌐 Professional Profiles

Education 📚

PhD in Medical Genetics Shahid Beheshti University of Medical Sciences, Tehran, Iran September 23, 2019 – October 7, 2023 PhD Thesis: Genetic investigation of non-obstructive azoospermia families with cytogenetic and molecular genetic tests, and determining the relationship between genetic and clinical findings of patients.M.Sc. in Cellular and Molecular Biology National Institute of Genetic Engineering and Biotechnology, Tehran, Iran September 23, 2010 – October 27, 2012 Master Thesis: Alkaloid extract of Peganum harmala L. seed on the expression of Bax and Bcl-2 genes involved in mitochondrial apoptosis pathway in cancer cells.B.Sc. in Molecular Genetics Shahrekord University, Shahrekord, Iran September 23, 2005 – October 7, 2009

Research Interests 🔬

  • Cancer Biology
  • Cancer Drug Resistance
  • Noncoding RNAs
  • Computational Biology
  • Genetics of Rare Diseases

Research Projects 🧬

Genetic analysis of male infertility in a family using Whole Exome Sequencing. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)In silico prediction of non-coding RNA-gene regulatory network in primary gonad failure defects. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)In silico identification of functional single nucleotide polymorphisms of azoospermia genes. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)In silico prediction of coagulation system functional polymorphisms. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)Identification of genes involved in Imatinib resistance in chronic myeloid leukemia (CML). (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)Genetic analysis of families with non-obstructive azoospermia by Whole Exome Sequencing. (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2024)Genetic investigation of infertility in an Iranian family with infertility in both sexes. (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2023)Prediction of tissue-specific inflammatory LncRNAs in COVID-19 patients. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2021-2024)Identification of inflammatory miRNAs associated with COVID-19 and determination of their potential target genes using bioinformatics tools. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2021-2023)Identification of genes involved in the development of chemotherapy resistance in lung cancer. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2021-2024)Identification of common polymorphisms in the host antioxidant pathway against viruses and prediction of their effects. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2021-2024)Identification of genes involved in the development of chemotherapy resistance in ovarian cancer. (Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2021-2023)Investigation of the effect of oleuropein on miR-125b and miR-34a expression in ovarian cancer cell lines. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2019-2020)Investigation of the effect of oleuropein on miR-181b and miR-21 expression in breast cancer cell line. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2019-2020)Investigation of the effect of oleuropein on the expression of genes involved in apoptosis in cisplatin-resistant ovarian cell line. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2019-2020)Study of the effect of nanoparticles containing altretiamine and arstin on ferroptosis in ovarian cancer cell line. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2016-2020)Study of the effect of nanoparticles containing altretamine on ferroptosis-apoptosis in ovarian cancer cell line. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2018-2019)Genetic etiology determination of non-syndromic hearing loss families using Whole Exome Sequencing. (Cellular and Molecular Research Center, Shahrekord University of Medical Sciences; 2018-2019)

Skills 🛠️

A. Experimental Techniques:Human cell cultureMTT assay (Drugs, Natural products, Nanoparticles)DNA and RNA extractionApoptosis assayROS assayElectrophoresisQuantitative PCRConventional PCRSonicationNanodropKaryotypingSanger sequencingWhole exome sequencingB. Software Ability:Various microRNA databases (TargetScan, miRBase, miRWalk, etc.)Various lncRNA databases (starBase, LncBase, etc.)Pathway databases (KEGG, WikiPathways, Reactome)Variant prediction tools (SIFT, Mutation Taster, Polyphen, CADD, etc.)Genome browsers (NCBI, Ensembl, UCSC)Primer design software and tools (AlleleID, Primer3, Oligo 7, etc.)Sequence analysis software (QIAGEN CLC Genomics Workbench, Mutation Surveyor, FinchTV, etc.)STRINGDBCytoscapeGene RunnerGenome expression databases (GEO, GTEx, etc.)

Workshops 📚

 

  • Various workshops covering topics such as predicting LncRNAs, the role of biological systems in cancer, electronic resource investigation, Next Generation sequencing, molecular techniques, article writing, PCR, and bioinformatics.

📚Top Noted Publication

  1. Title: The effect of oleuropein on apoptotic pathway regulators in breast cancer cells
    • Journal: European Journal of Pharmacology
    • Year: 2020
    • Volume: 886
    • Pages: 173509
    • Citations: 43

 

  1. Title: Peganum harmala L.’s anti-growth effect on a breast cancer cell line
    • Journal: Biotechnology reports
    • Year: 2015
    • Volume: 8
    • Pages: 138-143
    • Citations: 39

 

  1. Title: Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators
    • Journal: Life Sciences
    • Year: 2021
    • Volume: 278
    • Pages: 119525
    • Citations: 26

 

  1. Title: Growth inhibitory impact of Peganum harmala L. on two breast cancer cell lines
    • Journal: Iranian journal of biotechnology
    • Year: 2014
    • Volume: 12
    • Issue: 1
    • Pages: 8-14
    • Citations: 23

 

  1. Title: The impact of oleuropein on miRNAs regulating cell death signaling pathway in human cervical cancer cells
    • Journal: Biotechnology and Applied Biochemistry
    • Year: 2024
    • Volume: 71
    • Issue: 1
    • Pages: 61-71
    • Citations: 1

 

  1. Title: In Silico Prediction of Functional SNPs Interrupting Antioxidant Defense Genes in Relation to COVID-19 Progression
    • Journal: Biochemical Genetics
    • Year: 2024
    • Pages: 1-27

 

  1. Title: Meta-analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer
    • Journal: Cancer Reports
    • Year: 2023
    • Volume: 6
    • Issue: 12
    • Pages: e1884